Psoriasis
Conference Coverage
Systemic sclerosis overlap syndromes called distinct entity
Major finding: Musculoskeletal involvement occurred in 67% of patients with systemic sclerosis overlap syndromes, compared with 38% of those with...
Conference Coverage
Is PASI 90 becoming the new PASI 75?
News
New drugs, strategies advance rheumatoid arthritis treatment
Conference Coverage
Options exist for psoriasis patients with multiple anti-TNF failures
Conference Coverage
Treatment options expand for pulmonary arterial hypertension in scleroderma
Conference Coverage
Fixed maintenance secukinumab beats as-needed dosing
Major finding: Among psoriasis patients who achieved a PASI 75 response to 5 weeks of induction therapy with subcutaneous secukinumab, 59.7% who...
News
Adapting HCQ dose did not reduce SLE flare rates
Major finding: At 7 months of follow-up, the flare rates in patients with systemic lupus erythematosus were similar between those who received no...
News
Investigational biologic lessened symptoms in some patients with lupus
Major finding: The investigational biologic rigerimod was superior to placebo in patients with a higher lupus clinical disease activity score,...
News
Secukinumab soars in phase III psoriasis studies
Major finding: The PASI 75 response rate at 12 weeks in patients with moderate to severe chronic plaque psoriasis was 77.1% in those randomized to...
Conference Coverage
Psoriasis linked to nonalcoholic fatty liver disease
Major finding: The prevalence of nonalcoholic fatty liver disease in a large cohort of elderly subjects was 46.2% among those with psoriasis and...